Central Institute Of Mental Health, Mannheim

This study tests whether adding cannabidiol (CBD) to standard antipsychotic medication can help people with early schizophrenia manage their symptoms better and with fewer side effects. About 180 participants will receive either CBD or a placebo alongside their usual treatment fo…